J Med Chem 41:2911–2927CrossRefPubMed Bloom JD, Dutia MD, Johnson BD, Wissner A, Burns MG, Largis EE, Dolan JA, Claus TH (1992) Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316, 243). A potent beta-adrenergic agonist virtually specific for beta 3 S63845 datasheet receptors. A promising antidiabetic and antiobesity agent. J Med Chem 35:3081–3084CrossRefPubMed Brockunier LL, Parmee ER, Ok HO, Candelore MR, Cascieri MA, Colwell LF Jr, Deng L, Feeney WP, Forrest MJ, Hom GJ, MacIntyre DE, Tota L, Wyvratt MJ, Fisher MH, Weber AE (2000) Human beta3-adrenergic AMN-107 datasheet receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides.
Bioorg Med Chem Lett 10:2111–2114CrossRefPubMed Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967CrossRef Danforth E Jr, Himms-Hagen J (1997) Obesity and diabetes and the beta-3 adrenergic receptor. Eur J Endocrinol 136:362–365CrossRefPubMed deSouza CJ, Burkey BF (2001) Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans. Curr Pharm selleck chemicals Des 7:1433–1449CrossRef Dow RL (1997) Beta3-adrenergic agonists: potential therapeutics for obesity.
Exp Opin Invest Drugs 6:1811–1825CrossRef Feng DD, Biftu T, Candelore MR, Cascieri MA, Colwell LF Jr, Deng L, Feeney WP, Forrest MJ, Hom GJ, MacIntyre DE, Miller RR, Stearns RA, Strader CD, Tota L, Wyvratt MJ, Fisher MH, Weber AE (2000) Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonist. Bioorg Med Chem Lett 10:1427–1429CrossRefPubMed Furse KE, Lybrand TP (2003) Three-dimensional models for beta-adrenergic receptor complexes with agonists and antagonists. J Med Chem 46:4450–4462CrossRefPubMed Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electronegativity-a rapid access to atomic charges. Tetrahedron 36:3219–3228CrossRef Gavai AV, Sher PM, Mikkilineni AB, Poss KM, McCann PJ, Girotra RN, Fisher LG, Wu G, Bednarz MS, Mathur A, Wang TC, Sun CQ, Slusarchyk
DA, Skwish S, Allen GT, Hillyer DE, Frohlich BH, Abboa-Offei BE, Cap M, Waldron TL, George RJ, Tesfamariam B, Harper TW, Ciosek CP Jr, Young DA, Dickinson KE, Seymour AA, Arbeeny CM, Washburn FER WN (2001) BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptor. Bioorg Med Chem Lett 11:3041–3044CrossRefPubMed Gyanendra P, Sushil KK, Anil KS (2004) CoMFA, Advanced CoMFA and CoMSIA studies on the oxaiazole substituted α-isopropoxy phenylpropionic acids for PPARα agonistic activity. Med Chem Res 13:677–686CrossRef Harada H, Hirokawa Y, Suzuki K, Hiyama Y, Oue M, Kawashima H, Yoshida N, Furutani Y, Kato S (2003) Novel and potent human and rat beta3-adrenergic receptor agonists containing substituted 3-indolylalkylamines.